To the best of our knowledge, currently, there are no published systematic reviews on the role of 18F-PSMA-1007 PET/CT for PCa staging, whereas a systematic review on the role of 18F-PSMA-targeted agents in PCa restaging is already available [20]. Here, FOLH1 is linked to posterior cortical atrophy.